Articles Tagged With:
-
Only 1 HCW confirmed as occupationally infected with HIV in last 15 years, with 12 ‘possible’ cases
In the 1990s, tragic cases of healthcare workers who acquired AIDS and hepatitis on the job helped propel the movement for sharps safety. -
Nurses report bullying, disrespectful behavior by other nurses similiar to ‘hazing’
A common perception is that a lot of the bullying and disrespect that can create a toxic work culture in healthcare settings is directed by physicians toward nurses. -
Combination Therapy for Invasive Aspergillosis in Patients with Hematologic Malignancies or Hematopoeitic Cell Transplants
In an evaluation of the primary endpoint, all-cause mortality at 6 weeks, there was no statistically significant difference between treatment with voriconazole alone or in combination with anidulafungin in patients with invasive aspergillosis and hematologic malignancies or hematopoietic stem cell transplants.
-
Use screening tools, partnerships to improve identification, care of victims of IPV
With all the problems that emergency providers face on a daily basis, it can be especially difficult to identify and manage patients who may be victims of intimate partner violence (IPV). -
Palliative care options increase as CMs look for end-of-life care
After more than two decades, the concept of palliative care is gaining traction among case managers and other healthcare providers. -
New study highlights CM demographics
The Commission for Case Manager Certification (CCMC) conducts a thorough survey of case managers every five years, providing a snapshot of where the profession stands. -
Measles in Our Not-So-Magical Kingdom
ABSTRACT & COMMENTARY: Routine vaccination would have prevented most of these recent cases in California.
-
Experts: Market case management to younger HC professionals
Case management is facing a major brain drain in the next decade as the bulk of its membership heads toward retirement. -
Ticagrelor Cost Effective as Well as Efficacious, According to New Analysis
The PLATO trial randomized more than 18,000 acute coronary syndrome (ACS) patients to dual anti-platelet therapy with aspirin plus either clopidogrel or the newer P2Y12 inhibitor ticagrelor. Compared with clopidogrel-treated patients, those on ticagrelor had lower rates of death and myocardial infarction at 1 year. Despite superior ischemic outcomes, both ticagrelor and the thienopyridine prasugrel have been relatively slow to be adopted in the United States. This is at least in part due to the cost differential, as the older clopidogrel is available as a generic, while the newer agents enjoy continued brand exclusivity. The National Average Drug Acquisition Cost data collected by CMS currently reports a 70-fold difference in price between clopidogrel and ticagrelor.
-
Implantable Coronary Sinus Narrowing Device Shows Promise in Refractory Angina
Despite advances in medical therapy and in coronary revascularization techniques, the population of patients with chronic, stable, but debilitating angina continues to grow. The mortality of such patients is surprisingly low, such that patients with this disorder often suffer limiting symptoms for many years. Clearly more options for treatment are needed, but what?